chr15-48463253-T-TA

Variant summary

Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP6_Very_StrongBA1

The ENST00000316623.10(FBN1):​c.5066-14_5066-13insT variant causes a splice polypyrimidine tract, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0165 in 1,609,614 control chromosomes in the GnomAD database, including 618 homozygotes. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.023 ( 64 hom., cov: 33)
Exomes 𝑓: 0.016 ( 554 hom. )

Consequence

FBN1
ENST00000316623.10 splice_polypyrimidine_tract, intron

Scores

Not classified

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:14O:1

Conservation

PhyloP100: -0.716
Variant links:
Genes affected
FBN1 (HGNC:3603): (fibrillin 1) This gene encodes a member of the fibrillin family of proteins. The encoded preproprotein is proteolytically processed to generate two proteins including the extracellular matrix component fibrillin-1 and the protein hormone asprosin. Fibrillin-1 is an extracellular matrix glycoprotein that serves as a structural component of calcium-binding microfibrils. These microfibrils provide force-bearing structural support in elastic and nonelastic connective tissue throughout the body. Asprosin, secreted by white adipose tissue, has been shown to regulate glucose homeostasis. Mutations in this gene are associated with Marfan syndrome and the related MASS phenotype, as well as ectopia lentis syndrome, Weill-Marchesani syndrome, Shprintzen-Goldberg syndrome and neonatal progeroid syndrome. [provided by RefSeq, Apr 2016]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -16 ACMG points.

BP6
Variant 15-48463253-T-TA is Benign according to our data. Variant chr15-48463253-T-TA is described in ClinVar as [Benign]. Clinvar id is 178599.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.0771 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
FBN1NM_000138.5 linkuse as main transcriptc.5066-14_5066-13insT splice_polypyrimidine_tract_variant, intron_variant ENST00000316623.10 NP_000129.3
FBN1NM_001406716.1 linkuse as main transcriptc.5066-14_5066-13insT splice_polypyrimidine_tract_variant, intron_variant NP_001393645.1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
FBN1ENST00000316623.10 linkuse as main transcriptc.5066-14_5066-13insT splice_polypyrimidine_tract_variant, intron_variant 1 NM_000138.5 ENSP00000325527 P1

Frequencies

GnomAD3 genomes
AF:
0.0229
AC:
3471
AN:
151366
Hom.:
63
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0322
Gnomad AMI
AF:
0.0978
Gnomad AMR
AF:
0.0335
Gnomad ASJ
AF:
0.00780
Gnomad EAS
AF:
0.0835
Gnomad SAS
AF:
0.0475
Gnomad FIN
AF:
0.0146
Gnomad MID
AF:
0.0127
Gnomad NFE
AF:
0.00969
Gnomad OTH
AF:
0.0231
GnomAD3 exomes
AF:
0.0261
AC:
6549
AN:
250872
Hom.:
180
AF XY:
0.0248
AC XY:
3358
AN XY:
135616
show subpopulations
Gnomad AFR exome
AF:
0.0306
Gnomad AMR exome
AF:
0.0517
Gnomad ASJ exome
AF:
0.0104
Gnomad EAS exome
AF:
0.0764
Gnomad SAS exome
AF:
0.0400
Gnomad FIN exome
AF:
0.0107
Gnomad NFE exome
AF:
0.0101
Gnomad OTH exome
AF:
0.0252
GnomAD4 exome
AF:
0.0158
AC:
23076
AN:
1458132
Hom.:
554
Cov.:
32
AF XY:
0.0162
AC XY:
11777
AN XY:
725562
show subpopulations
Gnomad4 AFR exome
AF:
0.0323
Gnomad4 AMR exome
AF:
0.0509
Gnomad4 ASJ exome
AF:
0.0118
Gnomad4 EAS exome
AF:
0.110
Gnomad4 SAS exome
AF:
0.0354
Gnomad4 FIN exome
AF:
0.0118
Gnomad4 NFE exome
AF:
0.00903
Gnomad4 OTH exome
AF:
0.0207
GnomAD4 genome
AF:
0.0230
AC:
3482
AN:
151482
Hom.:
64
Cov.:
33
AF XY:
0.0243
AC XY:
1798
AN XY:
73998
show subpopulations
Gnomad4 AFR
AF:
0.0323
Gnomad4 AMR
AF:
0.0338
Gnomad4 ASJ
AF:
0.00780
Gnomad4 EAS
AF:
0.0837
Gnomad4 SAS
AF:
0.0480
Gnomad4 FIN
AF:
0.0146
Gnomad4 NFE
AF:
0.00969
Gnomad4 OTH
AF:
0.0228
Bravo
AF:
0.0251
Asia WGS
AF:
0.0720
AC:
252
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:14Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:3Other:1
not provided, no classification providedclinical testingLaboratory for Molecular Medicine, Mass General Brigham Personalized MedicineJun 05, 20145066-14_5066-13insT in intron 40 of FBN1: This variant is not expected to have clinical significance because it has been identified in 1% (85/8254) of European American chromosomes and 2.89% (123/4264) of African American chromosomes by the NHLBI Exome Sequencing Project, and it is not located within the splice consensus sequence. (http://evs.gs.washington.edu/EVS/; dbSNP rs3833018). -
Benign, no assertion criteria providedclinical testingGenome Diagnostics Laboratory, Amsterdam University Medical Center-- -
Benign, criteria provided, single submitterclinical testingPreventionGenetics, part of Exact Sciences-- -
Benign, no assertion criteria providedclinical testingGenome Diagnostics Laboratory, University Medical Center Utrecht-- -
Familial thoracic aortic aneurysm and aortic dissection Benign:2
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJun 14, 2016- -
Benign, criteria provided, single submitterclinical testingColor Diagnostics, LLC DBA Color HealthApr 08, 2018- -
not provided Benign:2
Benign, criteria provided, single submitterclinical testingGeneDxMay 30, 2018- -
Benign, criteria provided, single submitterclinical testingARUP Laboratories, Molecular Genetics and Genomics, ARUP LaboratoriesNov 16, 2021- -
Ectopia lentis Benign:1
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJun 14, 2016- -
Marfan syndrome Benign:1
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJun 14, 2016- -
Stiff skin syndrome Benign:1
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJun 14, 2016- -
Weill-Marchesani syndrome Benign:1
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJun 14, 2016- -
Geleophysic dysplasia Benign:1
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJun 14, 2016- -
Acromicric dysplasia Benign:1
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJun 14, 2016- -
Marfan syndrome;C4707243:Familial thoracic aortic aneurysm and aortic dissection Benign:1
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpFeb 01, 2024- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs3833018; hg19: chr15-48755450; API